JTT-705. Japan Tobacco.

Abstract

JTT-705 is a cholesteryl ester transfer protein inhibitor under development by Japan Tobacco Inc for the treatment of hyperlipidemia. The compound is undergoing phase I clinical trials in Japan and phase II clinical trials in Europe.

• Authors: Joannes T Linders
• Journal: Current opinion in investigational drugs (London, England : 2000) (Curr Opin Investig Drugs) Vol. 5 Issue 3 Pg. 339-43 (Mar 2004) ISSN: 1472-4472 [Print] England
• PMID: 15083602 (Publication Type: Journal Article, Review)

Chemical References

• Amides
• Esters
• Hypolipidemic Agents
• Sulfhydryl Compounds
• dalcetrapib

Topics

• Amides
• Animals
• Clinical Trials, Phase I as Topic
• Clinical Trials, Phase II as Topic
• Esters
• Humans
• Hyperlipidemias (drug therapy)
• Hypolipidemic Agents (chemical synthesis, chemistry, pharmacokinetics)
• Structure-Activity Relationship
• Sulfhydryl Compounds (chemical synthesis, chemistry, pharmacokinetics)